Inventor
VERKADE JORGE MERIJN MATHIEU
NL12 patents
Patents
12 patentsUS9636421B2May 2, 2017
Sulfamide linker, conjugates thereof, and methods of preparation
SYNAFFIX BV14 citations91
US11338043B2May 24, 2022
Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugates
SYNAFFIX BV8 citations82
US10072096B2Sep 11, 2018
Modified glycoprotein, protein-conjugate and process for the preparation thereof
SYNAFFIX BV9 citations82
US10792369B2Oct 6, 2020
Sulfamide linker, conjugates thereof, and methods of preparation
SYNAFFIX BV3 citations71
US11547763B2Jan 10, 2023
Enediyne conjugates
SYNAFFIX BV3 citations65
US11957763B2Apr 16, 2024
Sulfamide linkers for use in bioconjugates
SYNAFFIX BV0 citations61
US11951175B2Apr 9, 2024
Bioconjugates containing sulfamide linkers for use in treatment
SYNAFFIX BV1 citations61
US11850286B2Dec 26, 2023
Sulfamide linker, conjugates thereof, and methods of preparation
SYNAFFIX BV1 citations61
US11590239B2Feb 28, 2023
Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugates
SYNAFFIX BV0 citations57
US10874746B2Dec 29, 2020
Sulfamide linkers for use in bioconjugates
SYNAFFIX BV0 citations50
US12397063B2Aug 26, 2025
Antibody-conjugates for targeting of tumours expressing Trop-2
SYNAFFIX BV0 citations49
US12281135B2Apr 22, 2025
Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphate
SYNAFFIX BV0 citations49